Moderna's new version of its COVID-19 vaccine, which targets two virus variants ... states " will have the possibility to receive the expected updated bivalent booster candidate following approval ...

There are currently three vaccine candidates moving through the clinical pipeline in human trials right now, and the furthest along is Moderna ... of which are expected to be circulating Something ...

Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5 ...

The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.

Shares of Moderna tumbled Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year ...